neuer-LRC-Triceps-2016-pretest-kit, Ligand-receptor capture, LRC-TriCEPS by Dualsystems Biotech AG

Ligand-Receptor Binding – New LRC-TriCEPS™

We offer a novel service Ligand-receptor capture LRC-TriCEPS™ to identify the unknown targets / off-targets / receptors of your ligand on the living cells. The LRC-TriCEPS™crosslinker technology invented by Dr. Andreas Frei and Prof. Bernd Wollscheid from the ETH Zurich who published the technology in Nature Biotechnology (Frei et al.(2012) Nature Biotechnology 30:997-1001) has now been further developed by Prof. Bernd Wollscheid and Dualsystems Biotech AG. The next generation of TriCEPS™ is now available to Dualsystems Biotech customers.

Dualsystems Biotech is a service provider for custom proteomics for industry and academia. We are a biotech company form Schlieren near by Zurich, specialized in target deconvolution and elucidating protein-protein interaction in the living cells especially at the cell membrane.

For more details about ligand and receptor look on our website

Orphan ligands:

  • Extracellular proteins
  • Peptide ligands
  • Antibodies
  • Viruses
  • Engineered affinity binders

Principle of LRC-TriCEPS™ Technology


How do ligands bind to receptors? Watch our Video and see all about:

  • Ligand-receptor
  • Ligand-receptor binding
  • Ligand and receptor
  • Control ligand

Contact us

The next generation of LRC-TriCEPS™-based ligand-receptor capture technology is now available.

+41 44 738 50 00 or

Please contact us for more information

0 + 4 = ?

or more Services information about Dualsystems Biotech